Development of a Novel, Fully-Automated Genotyping System: Principle and Applications

Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer

(2015) Rodrigo Dienstmann et al.   Oncotarget

Rapid automated detection of ABL kinase domain mutations in imatinib-resistant patients

(2011) Ruriko Tanaka et al.   CANCER LETTERS

Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1*28 and/or UGT1A1*6 polymorphisms

(2011) Taroh Satoh et al.   CANCER SCIENCE

EGFR L858R Mutation and Polymorphisms of Genes Related to Estrogen Biosynthesis and Metabolism in Never-Smoking Female Lung Adenocarcinoma Patients

(2011) S.-Y. Yang et al.   CLINICAL CANCER RESEARCH

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype

(2011) K R Crews et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations

(2011) Tommaso De Pas et al.   Journal of Thoracic Oncology

A Noninvasive System for Monitoring Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors with Plasma DNA

(2011) Tomomi Nakamura et al.   Journal of Thoracic Oncology

Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia

(2011) S Wakita et al.   LEUKEMIA

A Fully Integrated and Automated Detection System for Single Nucleotide Polymorphisms of UGT1A1 and CYP2C19

(2011) Norio Ureshino et al.   ONCOLOGY RESEARCH

Mutaciones de sensibilidad y resistencia del gen epidermal growth factor receptor (EGFR) en el cáncer de pulmón de célula no pequeña: una realidad clínica

(2010) Álvaro Taus et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Use of K-Ras as a predictive biomarker for selecting anti-EGF receptor/pathway treatment

(2010) Yixing Jiang et al.   Biomarkers in Medicine

EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival?

(2010) Kenichi Suda et al.   Journal of Thoracic Oncology

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

(2010) Makoto Maemondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Assessment of K-rasmutation

(2009) Yixing Jiang et al.   CANCER

Clinically Available Pharmacogenomics Tests

(2009) DA Flockhart et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer

(2009) Salvatore Siena et al.   JNCI-Journal of the National Cancer Institute

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

(2009) Tetsuya Mitsudomi et al.   LANCET ONCOLOGY

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

(2009) A F Gazdar   ONCOGENE

Genetic Predictors of MEK Dependence in Non-Small Cell Lung Cancer

(2008) C. A. Pratilas et al.   CANCER RESEARCH

Proton pump inhibitors: an update of their clinical use and pharmacokinetics

(2008) Shaojun Shi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Fully automated and super-rapid system for the detection of JAK2V617F mutation

(2008) Ruriko Tanaka et al.   LEUKEMIA RESEARCH

K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer

(2008) Christos S. Karapetis et al.   NEW ENGLAND JOURNAL OF MEDICINE

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

(2008) C.-H. Yun et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA